233 related articles for article (PubMed ID: 12427903)
1. Ptosis as a remote effect of therapeutic botulinum toxin B injection.
Racette BA; Lopate G; Good L; Sagitto S; Perlmutter JS
Neurology; 2002 Nov; 59(9):1445-7. PubMed ID: 12427903
[TBL] [Abstract][Full Text] [Related]
2. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
Cardoso F
Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
[TBL] [Abstract][Full Text] [Related]
3. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin for the treatment of cervical dystonia.
Tintner R; Jankovic J
Expert Opin Pharmacother; 2001 Dec; 2(12):1985-94. PubMed ID: 11825330
[TBL] [Abstract][Full Text] [Related]
5. Autonomic function after botulinum toxin type A or B: a double-blind, randomized trial.
Tintner R; Gross R; Winzer UF; Smalky KA; Jankovic J
Neurology; 2005 Sep; 65(5):765-7. PubMed ID: 16157918
[TBL] [Abstract][Full Text] [Related]
6. Muscle paralysis produced by botulinum toxin type A injection in treated torticollis patients compared with toxin naive individuals.
Sloop RR; Cole D; Patel MC
Mov Disord; 2001 Jan; 16(1):100-5. PubMed ID: 11215566
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin treatment of axial and cervical dystonia.
Benecke R; Dressler D
Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystonia.
Naumann M; Yakovleff A; Durif F;
J Neurol; 2002 Jan; 249(1):57-63. PubMed ID: 11954869
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin therapy for cervical dystonia.
Walker FO
Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):749-66, vi. PubMed ID: 14580035
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of a new bulk toxin of botulinum toxin in cervical dystonia: a blinded evaluation.
Racette BA; McGee-Minnich L; Perlmutter JS
Clin Neuropharmacol; 1999; 22(6):337-9. PubMed ID: 10626093
[TBL] [Abstract][Full Text] [Related]
11. Unilateral ptosis: a rare presentation.
Farooq S; Dukht U; Jaffar S
J Pak Med Assoc; 2009 May; 59(5):319-21. PubMed ID: 19438140
[TBL] [Abstract][Full Text] [Related]
12. A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review.
Lang AM
Clin Ther; 2003 Aug; 25(8):2268-78. PubMed ID: 14512133
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin F in the treatment of torticollis clinically resistant to botulinum toxin A.
Sheean GL; Lees AJ
J Neurol Neurosurg Psychiatry; 1995 Dec; 59(6):601-7. PubMed ID: 7500097
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
Dessy LA; Fallico N; Mazzocchi M; Scuderi N
Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
[TBL] [Abstract][Full Text] [Related]
15. Further studies using higher doses of botulinum toxin type F for torticollis resistant to botulinum toxin type A.
Houser MK; Sheean GL; Lees AJ
J Neurol Neurosurg Psychiatry; 1998 May; 64(5):577-80. PubMed ID: 9598669
[TBL] [Abstract][Full Text] [Related]
16. Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial.
Mueller J
Mov Disord; 2009 May; 24(7):1098-9; author reply 1100. PubMed ID: 18942082
[No Abstract] [Full Text] [Related]
17. [Treatment of focal dystonia with botulinum toxin A].
Sojer M; Wissel J; Müller J; Poewe W
Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
[TBL] [Abstract][Full Text] [Related]
18. Persistence of Upper Blepharoptosis After Cosmetic Botulinum Toxin Type A.
Steinsapir KD; Groth MJ; Boxrud CA
Dermatol Surg; 2015 Jul; 41(7):833-40. PubMed ID: 26057409
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin injections for the treatment of hemifacial spasm over 16 years.
Sorgun MH; Yilmaz R; Akin YA; Mercan FN; Akbostanci MC
J Clin Neurosci; 2015 Aug; 22(8):1319-25. PubMed ID: 26100157
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin: description of injection techniques and examination of controversies surrounding toxin diffusion.
Lim EC; Seet RC
Acta Neurol Scand; 2008 Feb; 117(2):73-84. PubMed ID: 17850405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
